Literature DB >> 21106793

Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women.

Caroline Mitchell1, Kathleen Paul, Kathy Agnew, Reggie Gaussman, Robert W Coombs, Jane Hitti.   

Abstract

To assess the volume of genital fluid collected for measuring the HIV-1 RNA level in cervicovaginal fluid, phosphate-buffered saline containing 10 mM LiCl was used. Thirty-eight women provided 275 cervicovaginal specimens. The estimated median volume of cervicovaginal fluid was 0.51 ml (interquartile range, 0.33, 0.69).

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21106793      PMCID： PMC3043490          DOI： 10.1128/JCM.00991-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions.

Authors:  G C John; H Sheppard; D Mbori-Ngacha; R Nduati; D Maron; M Reiner; J Kreiss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-02-01       Impact factor: 3.731

2.  Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.

Authors:  Beverly E Sha; M Reza Zariffard; Qiong J Wang; Hua Y Chen; James Bremer; Mardge H Cohen; Gregory T Spear
Journal:  J Infect Dis       Date:  2004-12-02       Impact factor: 5.226

3.  Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group.

Authors:  P Baron; J Bremer; S S Wasserman; M Nowicki; B Driscoll; B Polsky; A Kovacs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

4.  Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays.

Authors:  L Bélec; D Meillet; M Lévy; A Georges; C Tévi-Bénissan; J Pillot
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

5.  Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.

Authors:  Richard A Zuckerman; Aldo Lucchetti; William L H Whittington; Jorge Sanchez; Robert W Coombs; Rosario Zuñiga; Amalia S Magaret; Anna Wald; Lawrence Corey; Connie Celum
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226
  5 in total
  29 in total

1.  A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.

Authors:  Jonathan T Su; Ryan S Teller; Priya Srinivasan; Jining Zhang; Amy Martin; Samuel Sung; James M Smith; Patrick F Kiser
Journal:  Pharm Res       Date:  2017-08-02       Impact factor: 4.200

2.  The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals That Target High-Mannose Glycans.

Authors:  Jacklyn Johnson; Manuel G Flores; John Rosa; Changze Han; Alicia M Salvi; Kris A DeMali; Jennifer R Jagnow; Amy Sparks; Hillel Haim
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

3.  Changes in the soluble mucosal immune environment during genital herpes outbreaks.

Authors:  Marla J Keller; Rebecca P Madan; Gail Shust; Colleen A Carpenter; N Merna Torres; Sylvia Cho; Hnin Khine; Meei-Li Huang; Lawrence Corey; Mimi Kim; Betsy C Herold
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

4.  Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide.

Authors:  Savas Tasoglu; David F Katz; Andrew J Szeri
Journal:  J Nonnewton Fluid Mech       Date:  2012-11       Impact factor: 2.670

5.  Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples.

Authors:  Scott A Churchman; John A Moss; Marc M Baum
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-03-02       Impact factor: 3.205

6.  Effect of the levonorgestrel intrauterine device on genital HIV-1 RNA shedding among HIV-1-infected women not taking antiretroviral therapy in Nairobi, Kenya.

Authors:  Jenell S Coleman; Christina Mwachari; Jennifer Balkus; Lucy Sanguli; Angela Muliro; Kathy Agnew; Robert W Coombs; Craig R Cohen; Jane Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

7.  Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time.

Authors:  Marta E Bull; Laura M Heath; Jennifer L McKernan-Mullin; Kelli M Kraft; Luis Acevedo; Jane E Hitti; Susan E Cohn; Kenneth A Tapia; Sarah E Holte; Joan A Dragavon; Robert W Coombs; James I Mullins; Lisa M Frenkel
Journal:  J Infect Dis       Date:  2013-01-11       Impact factor: 5.226

8.  Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis.

Authors:  Priya Srinivasan; Jining Zhang; Amy Martin; Kristin Kelley; Janet M McNicholl; Robert W Buckheit; James M Smith; Anthony S Ham
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

9.  Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.

Authors:  John A Moss; Irina Butkyavichene; Scott A Churchman; Manjula Gunawardana; Rob Fanter; Christine S Miller; Flora Yang; Jeremiah T Easley; Mark A Marzinke; Craig W Hendrix; Thomas J Smith; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

10.  Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.

Authors:  Lara E Pereira; Tyana Singletary; Amy Martin; Chuong T Dinh; Frank Deyounks; Angela Holder; Janet McNicholl; Karen W Buckheit; Robert W Buckheit; Anthony Ham; David F Katz; James M Smith
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.